Philippe Guerci: HIT after Cardiac Surgery – Are We Using the Right Tools?
Philippe Guerci, Professor at CHRU de Nancy, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cardiothoracic and Vascular Anesthesia, adding:
“New publication – HIT after cardiac surgery: are we using the right tools?
Work led by Thomas Klein, bringing together a highly talented team of hematobiologists (Philippe Savard, Toussaint Hacquard Marie, Emmanuel de Maistre, Thomas Lecompte), clinicians (Sandrine Grosjean, Guillaume Soyer) and methodologists-biostatisticians (Cedric Baumann, Amandine Luc, Elodie Jeanbert) across two expert centers.
Congratulations to all.
This bicentric study (Nancy 🇫🇷 and Dijon 🇫🇷) provides one of the most robust comparative evaluations to date of clinical scores for heparin-induced thrombocytopenia (HIT) in the challenging context of cardiac surgery with CPB.
Key findings:
- No clear winner among the 4 major HIT scores (4Ts, HEP, CPB, GFHT)
- All scores show excellent rule-out performance (NPV nearly 94–97%)
- Limited positive predictive value – caution against overdiagnosis
- Identification of a typical biphasic platelet pattern (early drop and delayed nadir nearly day 10) as a strong clinical signal
- The HEP score trends toward best overall performance, but without statistical superiority
Clinical message:
- In post-cardiac surgery patients, HIT scores are rule-out tools, not rule-in tools
- Diagnostic strategies must remain multimodal, combining clinical expertise with advanced functional assays
- This work highlights the strength of close collaboration between anesthesiologists, intensivists, and hematobiologists, essential to tackle complex perioperative coagulation disorders.
A great example of how bicenter collaboration enhances external validity and clinical relevance.”
Title: Evaluating Four HIT Prediction Scores After Cardiac Surgery With Cardiopulmonary Bypass: A Comparative Study
Authors: Guillaume Soyer, Philippe Savard, Philippe Guerci, Marie Toussaint Hacquard, Elodie Jeanbert, Amandine Luc, Cédric Baumann, Sandrine Grosjean, Emmanuel de Maistre, Thomas Lecompte, Thomas Klein

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention